Biomea Fusion stock opens 18
Biomea Fusion Inc. rallied out of the gate Friday, as shares of the California-based biopharmaceutical company focused
Biomea Fusion Inc. mobilized out of the door Friday, as portions of the California-put together biopharmaceutical organization centered with respect to therapy of hereditarily characterized tumors opened 17.6% over the first sale of stock cost. The organization said late Thursday its IPO, which was upsized to 9.0 million offers from 7.5 million offers, estimated at $17 an offer, at the highest point of the normal reach, as it raised $153 million and was esteemed at $463.6 million. The stock's first exchange was at $20.00 at 11:51 a.m. Eastern for 341,119 offers. The stock has pared a few increases from that point forward to exchange up 16.2% at $19.75. The organization opened up to the world on a day that the Renaissance IPO ETF fell 1.4% while the S&P 500 acquired 0.2%.